Prosthetic Joint Infections Overview

Principles

Definition

Prosthetic joint infections is a significant area of clinical research and medical science focused on the study of microbial colonization and proliferation occurring on or around implanted prosthetic joint components. This academic concept investigates the complex interplay between host factors, bacterial biofilms, and biomaterials, exploring their etiology, pathogenesis, diagnostic methods, therapeutic strategies, and preventative measures. The significance of this field lies in addressing a critical complication of arthroplasty that profoundly impacts patient morbidity, mortality, functional outcomes, and healthcare economics, necessitating interdisciplinary approaches to improve patient care and implant longevity.

Ontological type

Surgical Management

Diagnostic Strategies

Prevention and Prophylaxis

Key developments

Key Figures

Biofilm Recognition & Prevention era

William R. Jarvis [1], affiliated with Stanford University [3] and the University of California, San Diego [4], contributed to the Guideline for Prevention of Surgical Site Infection, 1999 [6], a foundational document guiding perioperative infection-control practices. This guideline [6] codified standardized prevention strategies for surgical sites, including aseptic technique, antibiotic prophylaxis, and perioperative surveillance, and thus shaped infection-control priorities in the prosthetic joint infection era. Teresa Horan [2], linked with Johns Hopkins University [5], contributed to the Guideline for Prevention of Surgical Site Infection, 1999 [6], reinforcing the emphasis on reducing surgical infections in implant care. This work helped translate biofilm-related prevention concepts into the Guideline for Prevention of Surgical Site Infection, 1999 [6], underpinning perioperative practices that reduced early implant inoculation and guided long-term management strategies.

Diagnostics-Guided Management era

Michael J. Rybak[1] was active at Rockefeller University[3] and Harvard University[4] during the Diagnostics-Guided Management era. Rybak[1] helped shape antimicrobial decision-making through the 2011 IDSA MRSA guidelines[6], a contribution crucial to aligning therapeutics with evolving diagnostic benchmarks in this era. Barbara E. Murray[2] was affiliated with Harvard University[4] and the Technical University of Denmark[5] during this era. Murray[2] contributed to the 2011 IDSA MRSA guidelines[6], reinforcing the diagnostic-guided management approach and the role of culture-driven decisions in prosthetic joint infections.

Consensus and Standardization era

Javad Parvizi[1], affiliated with Harvard University[3] and Stanford University[4] during this era, is a leading figure in consensus-driven prosthetic joint infection research and standardization. His key contributions include shaping The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria[7] and the Hip and Knee Section, What is the Definition of a Periprosthetic Joint Infection (PJI) of the Knee and the Hip? Can the Same Criteria be Used for Both Joints?[8], which standardized diagnostic criteria and consensus processes essential for uniform case classification and treatment pathways, and he highlighted the economic burden of PJI as shown in Periprosthetic Shoulder Infection in the United States: Incidence and Economic Burden[9]. Timothy L. Tan[2], affiliated with University of California, San Francisco[5] and Northwestern University[6] during this era, emerged as a pivotal figure in consensus-oriented prosthetic joint infection research. His pivotal contributions include The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria[7], Hip and Knee Section, Diagnosis, Algorithm: Proceedings of International Consensus on Orthopedic Infections[10], and Hip and Knee Section, What is the Definition of a Periprosthetic Joint Infection (PJI) of the Knee and the Hip? Can the Same Criteria be Used for Both Joints?[8], collectively advancing unified diagnosis algorithms and care pathways that enabled multicenter comparisons and standardized care in this era[7][8][10].